- Home
- CTCX vs ENSC Comparison
CTCX vs ENSC Comparison
Compare CTCX & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTCX
- ENSC
- Stock Information
- Founded
- CTCX 2007
- ENSC 2003
- Country
- CTCX United States
- ENSC United States
- Employees
- CTCX N/A
- ENSC 8
- Industry
- CTCX Medical/Dental Instruments
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- CTCX Health Care
- ENSC Health Care
- Exchange
- CTCX Nasdaq
- ENSC Nasdaq
- Market Cap
- CTCX 10.4M
- ENSC 9.5M
- IPO Year
- CTCX N/A
- ENSC N/A
- Fundamental
- Price
- CTCX $0.23
- ENSC $0.69
- Analyst Decision
- CTCX
- ENSC
- Analyst Count
- CTCX 0
- ENSC 0
- Target Price
- CTCX N/A
- ENSC N/A
- AVG Volume (30 Days)
- CTCX 1.3M
- ENSC 83.4M
- Earning Date
- CTCX 11-22-2024
- ENSC 11-12-2024
- Dividend Yield
- CTCX N/A
- ENSC N/A
- EPS Growth
- CTCX N/A
- ENSC N/A
- EPS
- CTCX N/A
- ENSC N/A
- Revenue
- CTCX $12,320.00
- ENSC $4,421,404.00
- Revenue This Year
- CTCX N/A
- ENSC N/A
- Revenue Next Year
- CTCX N/A
- ENSC N/A
- P/E Ratio
- CTCX N/A
- ENSC N/A
- Revenue Growth
- CTCX N/A
- ENSC 40.41
- 52 Week Low
- CTCX $0.20
- ENSC $0.14
- 52 Week High
- CTCX $4.31
- ENSC $2.06
- Technical
- Relative Strength Index (RSI)
- CTCX 36.41
- ENSC 61.12
- Support Level
- CTCX $0.25
- ENSC $0.62
- Resistance Level
- CTCX $0.38
- ENSC $0.81
- Average True Range (ATR)
- CTCX 0.04
- ENSC 0.15
- MACD
- CTCX -0.00
- ENSC 0.01
- Stochastic Oscillator
- CTCX 20.28
- ENSC 53.71
About CTCX Carmell Corporation
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.